News

A team of engineers from Rice University have developed a flexible octopus-like robot arm that is controlled by laser beams.
Nektar's lead candidate, rezpeg, hits key targets in a phase IIb eczema study, sending shares soaring 156.3% on Tuesday.
The DHODH inhibitor market is poised for steady growth, fueled by the rising burden of autoimmune and inflammatory diseases, along with incre ...
Carmil Therapeutics to develop next-generation immunotherapies based on this innovationParis & Le Genest St Isle, June 23, 2025 Carmil Therapeutics today announces the publication of a landmark ...
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 25, 2025 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric ...
Menopausal Hormone Therapy (MHT) is first-line treatment for the relief of menopausal symptoms. Although the majority of ...